
Bislol Plus5 mg+6.25
Opsonin Pharma Ltd.
Bisoprolol Fumarate + Hydrochlorothiazide is a fixed-dose combination product containing bisoprolol fumarate, a beta-1 selective (cardioselective) adrenergic receptor blocker, and hydrochlorothiazide and more.
Bisoprolol Fumarate + Hydrochlorothiazide is a fixed-dose combination product containing bisoprolol fumarate, a beta-1 selective (cardioselective) adrenergic receptor blocker, and hydrochlorothiazide, a thiazide diuretic. It is FDA-approved for the following use:
Bisoprolol Fumarate + Hydrochlorothiazide is generally used as a second-line combination therapy - that is, in patients whose blood pressure is not adequately controlled on either component (a beta-blocker or a thiazide diuretic) alone, or as maintenance therapy once individual doses of each component have been titrated. Bisoprolol Fumarate + Hydrochlorothiazide is not intended for initial therapy of hypertension unless a physician determines that the patient is likely to need multiple drugs to achieve their blood pressure goal.
This combination is not indicated for conditions such as angina, arrhythmia, or heart failure; individual components have other approved uses but this specific fixed-dose combination is approved for hypertension only.
Bisoprolol Fumarate + Hydrochlorothiazide is generally used once the individual doses of bisoprolol and hydrochlorothiazide have been separately titrated, or when a patient's hypertension is not adequately controlled by either component alone. Dosing must be individualized by a physician.
| Indication | Population | Typical Dosing |
|---|---|---|
| Hypertension | Adults - initial therapy | One tablet of the lowest strength combination (e.g., 2.5 mg/6.25 mg) once daily, taken in the morning, with or without food. |
| Hypertension | Adults - titration | Dose may be increased at intervals of approximately 14 days, based on blood pressure response, up to a maximum of 20 mg bisoprolol / 12.5 mg hydrochlorothiazide once daily. |
| Hypertension | Renal impairment | Use with caution; thiazides may be less effective and beta-blocker clearance may be reduced in significant renal impairment. Dose adjustment and closer monitoring may be needed - consult a physician. |
| Hypertension | Hepatic impairment | Use with caution; bisoprolol undergoes partial hepatic metabolism. No fixed dose adjustment is well established; individualize dosing. |
Like all medicines, Bisoprolol Fumarate + Hydrochlorothiazide can cause side effects, although not everyone experiences them.
Bisoprolol Fumarate + Hydrochlorothiazide is contraindicated in patients with:
Additional cautions (e.g., severe asthma/bronchospastic disease, uncontrolled heart failure) are discussed under Precautions and Warnings, as these generally represent relative rather than absolute contraindications requiring careful clinical judgment.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.